Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors
SG001（一种人源化抗PD-1抗体）治疗晚期实体瘤患者的1b期多中心研究
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S546663
Fang, Jian; Jiang, Ou; Li, Wei; Lin, Jie; Fang, Meiyu; Li, Qun; Zhao, Weihong; Wang, Ke; Shi, Huaqiu; Chen, Zhendong; Yu, Junyan; Xing, Xiaojing; Zhao, Mingxuan; Liu, Anwen; Wang, Wei; Han, Zhengquan; Xiang, Silong; Zhang, Xiao; Li, Jin; Zhou, Caicun
